BioNexus Gene Lab (BGLC) Other Non Operating Income (2019 - 2026)

BioNexus Gene Lab has disclosed Other Non Operating Income across 7 years of filings, most recently posting $57686.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $57686.0, down 36.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $398383.0 (down 79.7% YoY), and the FY2025 annual result was $432117.0, down 79.15% from the prior year.
• Other Non Operating Income came in at $57686.0 for Q1 2026 at BioNexus Gene Lab, up from $23476.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $730105.0 in Q2 2024 to a low of -$68776.0 in Q1 2022.
• The 4-year median for Other Non Operating Income is $154803.5 (2024), against an average of $249350.0.
• Across the five-year window, Other Non Operating Income surged 67.01% in 2022 and plunged 96.52% in 2025, its largest moves.
• BioNexus Gene Lab's Other Non Operating Income stood at -$68776.0 in 2022, then soared by 1081.44% to $674994.0 in 2024, then slumped by 96.52% to $23476.0 in 2025, then soared by 145.72% to $57686.0 in 2026.
• The last three Other Non Operating Income figures came in at $57686.0 (Q1 2026), $23476.0 (Q4 2025), and $107760.0 (Q3 2025), per Business Quant data.